Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Pharmacorp Rx Inc. ( (TSE:PCRX) ) is now available.
PharmaCorp Rx Inc. announced an executive transition with Paul Dale appointed as President and Chief Operating Officer, succeeding Calvin LeRoux who will serve as Strategic Advisor to the CEO. This transition is part of PharmaCorp’s national expansion strategy, reinforcing its operational continuity and leadership strength. Additionally, Sophia Sigler will join as Director of Business Development to lead acquisition and transaction efforts, supporting the company’s growth and strategic initiatives.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. is a Canadian pharmacy acquisition and ownership platform that focuses on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. The company is building a national network of community pharmacies under the PharmaChoice Canada banner, currently operating seven such pharmacies and aiming to acquire more across Canada.
Average Trading Volume: 103,504
Technical Sentiment Signal: Sell
Current Market Cap: C$68.6M
Find detailed analytics on PCRX stock on TipRanks’ Stock Analysis page.